Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tamborero

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
The American Journal of Cardiology|June 30, 2007
Usefulness of ventricular dyssynchrony measured using M-mode echocardiography to predict response to resynchronization therapyErnesto Díaz-Infante, Marta Sitges, Bàrbara Vidal, et al.
The American Journal of Cardiology|September 11, 2007
Optimizing the programation of cardiac resynchronization therapy devices in patients with heart failure and left bundle branch blockBàrbara Vidal, Marta Sitges, Alba Marigliano, et al.
Oncotarget|September 17, 2017
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testingMuntasir Mamun Majumder, Raija Silvennoinen, Pekka Anttila, et al.
Cancers|July 29, 2025
Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical ResponseRita Hutyra-Gram Ötvös, Hanna Krynska, Greta Gudoityte, et al.
European Journal of Heart Failure|April 3, 2010
Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapyJose María Tolosana, Lluís Mont, Marta Sitges, et al.
American Journal of Human Genetics|December 2, 2025
Interpreting the functional impact of genetic variants: The need for context qualifiersSimone Martinelli, Hélène Cavé, Alessandro De Luca, et al.
Genome Medicine|March 30, 2018
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterationsDavid Tamborero, Carlota Rubio-Perez, Jordi Deu-Pons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2018
NK Cell Infiltrates and HLA Class I Expression in Primary HER2<sup>+</sup> Breast Cancer Predict and Uncouple Pathological Response and Disease-free SurvivalAura Muntasell, Federico Rojo, Sonia Servitja, et al.
The American Journal of Cardiology|August 6, 2008
Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study)Jose Maria Tolosana, Antonio Hernandez Madrid, Josep Brugada, et al.
Journal of Cardiac Failure|March 31, 2010
Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administrationMontserrat Rigol, Núria Solanes, Jordi Farré, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
The American Journal of Cardiology|June 30, 2007
Usefulness of ventricular dyssynchrony measured using M-mode echocardiography to predict response to resynchronization therapyErnesto Díaz-Infante, Marta Sitges, Bàrbara Vidal, et al.
The American Journal of Cardiology|September 11, 2007
Optimizing the programation of cardiac resynchronization therapy devices in patients with heart failure and left bundle branch blockBàrbara Vidal, Marta Sitges, Alba Marigliano, et al.
Oncotarget|September 17, 2017
Identification of precision treatment strategies for relapsed/refractory multiple myeloma by functional drug sensitivity testingMuntasir Mamun Majumder, Raija Silvennoinen, Pekka Anttila, et al.
Cancers|July 29, 2025
Ex Vivo Drug Sensitivity of Pleural Effusion-Derived Cells from Lung Cancer and Pleural Mesothelioma Patients Is Linked to Clinical ResponseRita Hutyra-Gram Ötvös, Hanna Krynska, Greta Gudoityte, et al.
European Journal of Heart Failure|April 3, 2010
Plasma tissue inhibitor of matrix metalloproteinase-1 (TIMP-1): an independent predictor of poor response to cardiac resynchronization therapyJose María Tolosana, Lluís Mont, Marta Sitges, et al.
American Journal of Human Genetics|December 2, 2025
Interpreting the functional impact of genetic variants: The need for context qualifiersSimone Martinelli, Hélène Cavé, Alessandro De Luca, et al.
Genome Medicine|March 30, 2018
Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterationsDavid Tamborero, Carlota Rubio-Perez, Jordi Deu-Pons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2018
NK Cell Infiltrates and HLA Class I Expression in Primary HER2<sup>+</sup> Breast Cancer Predict and Uncouple Pathological Response and Disease-free SurvivalAura Muntasell, Federico Rojo, Sonia Servitja, et al.
The American Journal of Cardiology|August 6, 2008
Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study)Jose Maria Tolosana, Antonio Hernandez Madrid, Josep Brugada, et al.
Journal of Cardiac Failure|March 31, 2010
Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administrationMontserrat Rigol, Núria Solanes, Jordi Farré, et al.
Pageof 7